A hyper-ferritinemia syndrome evolving in recurrent macrophage activation syndrome, as an onset of amyopathic juvenile dermatomyositis: A challenging clinical case in light of the current diagnostic criteria

被引:32
作者
Poddighe, Dimitri [1 ]
Cavagna, Lorenzo [2 ]
Brazzelli, Valeria [3 ]
Bruni, Paola [1 ]
Marseglia, Gian Luigi [4 ,5 ]
机构
[1] Azienda Osped Melegnano, Dept Pediat, I-20070 Milan, Italy
[2] Fdn Policlin San Matteo Pavia, IRCCS, Dept Rheumatol, Pavia, Italy
[3] Fdn Policlin San Matteo Pavia, IRCCS, Dept Dermatol, Pavia, Italy
[4] Fdn Policlin San Matteo, IRCCS, Dept Pediat, Pavia, Italy
[5] Univ Pavia, I-27100 Pavia, Italy
关键词
Juvenile dermatomyositis; Macrophage activation syndrome; Epstein-Barr virus; Hyperferritinemia; SYSTEMIC-LUPUS-ERYTHEMATOSUS; GUIDELINES; FEATURES;
D O I
10.1016/j.autrev.2014.05.009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Juvenile dermatomyositis is an immune-mediated inflammatory multi-system disease involving mainly striated muscles and skin. Typical dermatological features are fundamental to establish the diagnosis, especially whenever the myopathy is very mild or absent, as it occurs in the form called as amyopathic juvenile dermatomyositis. Sometimes, systemic rheumatic diseases can develop a hyperferritinemia syndrome characterized by hemophagocytosis, namely macrophage activation syndrome, which represents a severe and life-threatening complication. Here, we describe a complex clinical history characterized by a hyper-ferritinemia syndrome after infectious mononucleosis, leading to recurrent episodes of macrophage activation syndrome. Finally, the late onset of several skin changes brought to a diagnosis of amyopathic juvenile dermatomyositis. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:1142 / 1148
页数:7
相关论文
共 25 条
  • [1] [Anonymous], INT J RHEUM DIS
  • [2] Atteritano M, 2012, EUR REV MED PHARMACO, V16, P1414
  • [3] Juvenile Dermatomyositis
    Batthish, Michelle
    Feldman, Brian M.
    [J]. CURRENT RHEUMATOLOGY REPORTS, 2011, 13 (03) : 216 - 224
  • [4] Behrens EM, 2007, J RHEUMATOL, V34, P1133
  • [5] Inflammatory myopathies in children
    Compeyrot-Lacassagne, S
    Feldman, BM
    [J]. PEDIATRIC CLINICS OF NORTH AMERICA, 2005, 52 (02) : 493 - +
  • [6] Epstein-Barr Virus in Systemic Autoimmune Diseases
    Draborg, Anette Holck
    Duus, Karen
    Houen, Gunnar
    [J]. CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2013,
  • [7] Clinical features and disease course of patients with juvenile dermatomyositis
    Gowdie, Peter J.
    Allen, Roger C.
    Kornberg, Andrew J.
    Akikusa, Jonathan D.
    [J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2013, 16 (05) : 561 - 567
  • [8] Primary and secondary hemophagocytic lymphohistiocytosis: clinical features, pathogenesis and therapy
    Gupta, Sumit
    Weitzman, Sheila
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2010, 6 (01) : 137 - 154
  • [9] HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis
    Henter, Jan-Inge
    Horne, AnnaCarin
    Arico, Maurizio
    Egeler, R. Maarten
    Filipovich, Alexandra H.
    Imashuku, Shinsaku
    Ladisch, Stephan
    McClain, Ken
    Webb, David
    Winiarski, Jacek
    Janka, Gritta
    [J]. PEDIATRIC BLOOD & CANCER, 2007, 48 (02) : 124 - 131
  • [10] Familial and acquired hemophagocytic lymphohistiocytosis
    Janka, Gritta E.
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 2007, 166 (02) : 95 - 109